French firm Valneva was supposed to manufacture more than 100 million vaccines at its site in Livingston but the contract was axed by ministers in 2021.
A biotechnology company which had its contract to make Covid vaccines in Scotland cancelled by the UK Government still received £358 million of taxpayers’ money, it has emerged.
A form filed with the United States Securities and Exchange Commission states Valneva received advances totalling £358 million as part of its agreement with the UK Government. It was reported this week by the BBC that the French firm has hired a commercial real estate firm to explore options for the mothballed 75,000sq ft facility.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Emmerdale actor axed for threatening to stab co-star wins role in Disney filmSACKED Emmerdale actor Asan N’jie has bagged a role in a new Disney movie. The lad, 28, was axed from the ITV soap back in 2019 after he threatened to stab rival soap star Jamie Lomas, 48, at the T…
Weiterlesen »
Meghan Markle accused of FAKING interviews for axed £18M Spotify podcastMEGHAN Markle has been accused of faking a number of interviews for her axed Archetypes podcast by industry sources. They claim the Duchess of Sussex, 41, had staff on the show conduct some intervi…
Weiterlesen »
Meghan Markle is accused of faking interviews with stars in axed Spotify podcastMeghan Markle has been accused of faking interviews with her celebrity guests on her Archetypes podcast just days after it was axed from Spotify after just 12 episodes
Weiterlesen »
Braverman’s triple racism whammyBraverman’s triple racism whammy 💀 Stop and search “ramped up” 💀BNP-style “sons and daughters” housing policy 💀Windrush scandal prevention team axed HackneyAbbott slams 'outrageous' multiple assault on Black community
Weiterlesen »
Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial - BMC Infectious DiseasesBackground Shortly after the Coronavirus disease 2019 (COVID-19) pandemic, a considerable number of recovered patients reported persisting symptoms, especially neuropsychological manifestations, which were later named post-COVID syndrome (PCS). Immune dysregulation was suggested as one of the main mechanisms for PCS. Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) that is mostly used to treat depression, anxiety disorders, and obsessive–compulsive disorder, has been suggested as an anti-COVID drug due to its anti-inflammatory effects, mainly through the sigma-1 receptor. Therefore, we aimed to evaluate fluvoxamine's effect on PCS neuropsychiatric symptoms. Method In this double-blind randomized clinical trial, we included confirmed mild to moderate COVID-19 outpatients using polymerase chain reaction (PCR) by an infectious disease specialist. The presence of severe COVID-19 symptoms was evaluated by the infectious disease specialist and included dyspnea, SpO2 30 breaths/min, and lung infiltrates | 50%. Then we performed permuted block randomization and assigned patients 1:1 into two groups to either receive fluvoxamine 100 mg tablet or a placebo daily for 10 days. Eligible patients were evaluated after 12 weeks for the presence of fatigue, as the primary, and other PCS symptoms as secondary outcomes. Results We screened a total of 486 patients from March to June 2022. After 12 weeks, 42 patients receiving fluvoxamine and 43 patients receiving Placebo were evaluated for PCS. Patients had a mean age of 38.5 ± 14.1 and 48% of them were women. Fatigue was significantly lower in the fluvoxamine group (p-value 0.026). No significant differences were observed in other symptoms. Conclusion We concluded that taking fluvoxamine during active COVID-19 can reduce the chance of fatigue but the advantage of fluvoxamine was not observed for other symptoms. Further studies are necessary to confirm these preliminary results.
Weiterlesen »
Tory aides invited to 'Jingle and Mingle' Covid partyIt was sent on behalf of Ben Mallet, a former aide to Boris Johnson, who was awarded an OBE last week.
Weiterlesen »